Andrey Vishnevskiy

Andrey Vishnevskiy

Auto-generated profile, based on publicly available information

Andrey Vishnevskiy

Vladivostok State University of Economics and Service, Institute of Information Technologies

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MTM. M. Tsivanyuk
M. M. Tsivanyuk
BGB. I. Geltser
B. I. Geltser
KSK. I. Shakhgeldyan
K. I. Shakhgeldyan
AVA. A. Vishnevskiy
A. A. Vishnevskiy
OSO. I. Shekunova
O. I. Shekunova
Aim. To evaluate the predictive potential of the parameters of complete blood count (CBC), lipid profile and their ratios for predicting obstructive coronary artery disease (oCAD) in patients with non-ST elevation acute coronary syndrome (NSTEACS).Material and methods. The study included 600 patients with NSTE-ACS with a median age of 62 years who underwent invasive coronary angiography (CA). Two groups were formed, the first of which consisted of 360 (60%) patients with oCAD (stenosis ≥50%), and the second — 240 (40%) with coronary stenosis 55 years in men and >65 years in women, lymphocyte count (LYM) 49%, immune-inflammation index >1000, high density lipoprotein cholesterol (HDL-C) to low density lipoprotein cholesterol (LDL-C) ratio 0,8, neutrophil (NEUT)-to-HDL-C ratio >5,7 and NEUT/LYM >3. The relative contribution of individual predictors to the development of end point was determined.Conclusion. The predictive algorithm (model 9), developed on the basis of MLR, showed a better quality metrics ratio than other models. The following 3 factors had the dominant influence on the oCAD risk: HDL-C/LDL-C (38%), age of patients (31%), and MON/HDL-C (14%). The influence of other factors on the oCAD risk was less noticeable.

25 June 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
BGB. I. Geltser
B. I. Geltser
MTM. M. Tsivanyuk
M. M. Tsivanyuk
KSK. I. Shakhgeldyan
K. I. Shakhgeldyan
EEE. D. Emtseva
E. D. Emtseva
AVA. A. Vishnevskiy
A. A. Vishnevskiy
Aim. To develop predictive models of obstructive coronary artery disease (OPCA) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) based on the predictive potential of cardiometabolic risk (CMR) factors.Material and methods. This prospective observational cohort study included 495 patients with NSTE-ACS (median age, 62 years; 95% confidence interval [60; 64]), who underwent invasive coronary angiography (CAG). Two groups of persons were identified, the first of which consisted of 345 (69,6%) patients with OPCA (stenosis ≥50%), and the second — 150 (30,4%) without OPCA (3,5 mmol/L, waist-to-hip ratio ≥0,9, waist-to-height ratio ≥0,69, atherogenic index ≥3,4, lipid accumulation product index ≥38,5 cm*mmol/L, uric acid ≥356 pmol/L) and 2 continuous (high density lipoprotein cholesterol and insulin resistance index) variables.Conclusion. The developed algorithm for selecting predictors made it possible to determine their significant predictive threshold values and weighting coefficients characterizing the degree of influence on endpoints. The ensemble of MLR models demonstrated the highest accuracy of OPCA prediction before the CAG. The predictive accuracy of the SVM and RF models was significantly lower.

19 August 2026 in JMIR Medical Informatics
Verified
Journal Article
Open access
VRVyacheslav Ryabov
Vyacheslav Ryabov
ANAnastasiia Nesova
Anastasiia Nesova
AVAndrey A Vishnevskiy
Andrey A Vishnevskiy
KSKarina I Shakhgeldyan
Karina I Shakhgeldyan
BGBoris I Geltser
Boris I Geltser
Background: Despite advances in understanding and treating non–ST-elevation acute coronary syndrome (NSTE-ACS), patients continue to experience high rates of adverse outcomes, particularly those with non–ST-segment elevation myocardial infarction, which remains a leading cause of cardiovascular mortality. Existing risk models may not fully reflect contemporary patient populations due to substantial changes in clinical profiles. Developing new machine learning (ML)–based risk calculators may improve the prediction of in-hospital mortality (IHM) at different stages of the diagnostic process, and ultimately improve patient outcomes. Objective: This study aimed to develop predictive models for IHM in patients with NSTE-ACS using ML methods and predictor sets obtained during the diagnostic process. Methods: This retrospective observational study included 1144 patients with NSTE-ACS admitted between 2019 and 2021. IHM occurred in 94 (8.1%) of 1144 patients. Predictive models were developed using multivariable logistic regression, Random Forest, XGBoost (Extreme Gradient Boosting), and CatBoost algorithms. Model performance was evaluated using the area under the receiver operating characteristic curve (ROC-AUC), area under the precision-recall curve, calibration metrics, and decision curve analysis. Results: A key feature of the developed models was their applicability at different stages of the diagnostic process, using predictors available at each specific stage. At admission, ML models achieved ROC-AUC values up to 0.93. After incorporating laboratory and echocardiographic data, predictive performance increased to ROC-AUC values of 0.94 to 0.95. The best-performing model demonstrated an ROC-AUC of 0.951 (95% CI 0.946‐0.956), a sensitivity of 0.902 (95% CI 0.889‐0.916), and a specificity of 0.891 (95% CI 0.886‐0.896). The area under the precision-recall curve reached 0.685, and the Brier score was 0.0331, indicating good calibration. Random Forest models demonstrated greater clinical utility than the Global Registry of Acute Coronary Events score ( P <.001). Shapley Additive Explanations analysis identified the most significant predictors of mortality risk, including Killip class of acute heart failure, age, Charlson comorbidity index, creatinine level, and hematocrit level. Conclusions: ML-based models enabled accurate prediction of IHM in patients with NSTE-ACS at different stages of the diagnostic process and may improve risk stratification and clinical decision-making in real-world practice.

4 October 2021
Verified
Book Chapter
Closed access
PDF file
KSKarina Shakhgeldyan
Karina Shakhgeldyan
BGBoris Geltser
Boris Geltser
VRVladislav Rublev
Vladislav Rublev
AVAndrey Vishnevskiy
Andrey Vishnevskiy
EEElena Emtseva
Elena Emtseva
MTMikhail Tsivanyuk
Mikhail Tsivanyuk